First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
Xiaopeng Tian, Jun Cai, Yi Xia, Yuchen Zhang, Liang Wang, Panpan Liu, Huiqiang Huang, Yajun Li, Hui Zhou, Zhiming Li, H. J. Yang, Liqiang Wei, Qi-Hua Zou, Ying Huang, Jun Li, Ling Li, Wen-Long Zhong, Qingqing Cai
Topics & Concepts
MedicineOxaliplatinGemcitabineLymphomaInternal medicineOncologyRefractory (planetary science)Phases of clinical researchT-cell lymphomaNatural killer T cellChemotherapyImmunologyCancerT cellImmune systemAstrobiologyPhysicsColorectal cancerLymphoma Diagnosis and TreatmentHead and Neck Cancer StudiesImmune Cell Function and Interaction